Stocks and Investing Stocks and Investing
Tue, May 24, 2022
Mon, May 23, 2022
Sat, May 21, 2022
Fri, May 20, 2022

Kevin Heal Downgraded (ALL) to Hold on, May 20th, 2022


Published on 2024-10-27 21:13:38 - WOPRAI, Kevin Heal
  Print publication without navigation


Kevin Heal of Argus Research, Downgraded "The Allstate Corporation" (ALL) to Hold on, May 20th, 2022.

Kevin has made no other calls on ALL in the last 4 months.



There are 9 other peers that have a rating on ALL. Out of the 9 peers that are also analyzing ALL, 3 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yaron Kinar of "Jefferies" Maintained at Hold with Increased Target to $135 on, Tuesday, May 10th, 2022
  • Tracy Benguigui of "Barclays" Maintained at Hold with Decreased Target to $132 on, Monday, May 9th, 2022
  • Michael Phillips of "Morgan Stanley" Maintained at Hold with Increased Target to $152 on, Thursday, April 14th, 2022


These are the ratings of the 6 analyists that currently disagree with Kevin


  • Elyse Greenspan of "Wells Fargo" Maintained at Sell with Decreased Target to $120 on, Friday, May 6th, 2022
  • Andrew Kligerman of "Credit Suisse" Initiated at Buy and Held Target at $188 on, Thursday, April 28th, 2022
  • Paul Newsome of "Piper Sandler" Maintained at Buy with Decreased Target to $147 on, Friday, April 22nd, 2022
  • C. Gregory Peters of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $165 on, Friday, March 18th, 2022
  • Alex Scott of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $142 on, Thursday, March 3rd, 2022
  • Brian Meredith of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $149 on, Monday, February 14th, 2022